Compare Lennar Corporation (LEN) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lennar Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Lennar Corporation trades at $87.46 (market cap $21.05B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Lennar Corporation pays a 2.28% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Lennar Corporation nearer its low. Which is the better fit depends on your goals.
| LEN | XBI | |
|---|---|---|
Market Cap | $21.05B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $142.40 | $164.28 |
52-Week Low | $81.84 | $86.92 |
Enterprise Value | $24.93B | — |
Dividend Yield | 2.28% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
